Research & Education

Smoking, Cessation, and the Cancer Patient: Clinical, Biologic, and Behavioral Considerations

Wednesday, January 21, 2015 - Recording Available
   
Graham Warren, MD, PhD
Associate Professor
Vice Chairman for Research in Radiation Oncology
Director, Hollings Cancer Center Tobacco Cessation Program
Department of Radiation Oncology
Department of Cell and Molecular Pharmacology and Experimental Therapeutics
Hollings Cancer Center
Medical University of South Carolina

Carolyn Dresler, MD
Moderator
International Association for the Study of Lung Cancer Board of Directors

 

Name of Reviewer(s): 

              

Dr. Fred Hirsch- Speakers Bureau/Advisory Board: Astrazeneca, Genentech, BMS, Lilly and Abbvie.

Name of Planner(s): 

 

    Deb Whippen-Nothing to Disclose

Name of Activity: 

 

Smoking, Cessation, and the Cancer Patient: Clinical, Biologic, and Behavioral Considerations

Date of Activity:

 

01/21/2015,  Webinar

Faculty/Speaker(s):

 

Graham Warren, MD, PhD  - Speaker-

Chair,ASCO Tobacco Subcommittee

Member, AACR & IASLC Tobacco Subcommittee

Chair, MUSC Tobacco Subcommittee

Editorial Board , JTO and CEBP

Carolyn Dresler, MD- Moderator- Nothing to Disclose

Type of Activity: 

 Live Course

  Internet Live Course (Webinar)XXXX

 Internet Enduring Material

Are there Commercial Supporters for this activity?

     No

If yes, please list:

Registration is taken on a first-come first-served basis, participation is limited.

IASLC presents this webinar featuring Dr. Graham Warren. This webinar will discuss the known biological effects of smoking on cancer cell biology and emphasize the clinical effects of continued smoking in patients with lung cancer treated with surgery, chemotherapy and/or radiotherapy. We also address the variables to consider in the design and implementation of a sustainable tobacco cessation program for lung cancer patients.
 
Following the presentation, there will be ample time for discussion and questions. Attendees will be able to submit questions and comments to Dr. Warren via internet chat.
After attending this program, participants will:

  • Illustrate  the clinical effects of tobacco use on cancer treatment outcomes
  • Identify the known and unknown biologic effects of cigarette smoke on cancer biology
  • Describe current approaches to addressing tobacco use in oncology practice and research
  • Develop an approach to improve access to structured tobacco cessation support for cancer patients

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.

CME INFORMATION:

IASLC Policy on Financial/Commercial Relationships & Conflicts of Interest

IASLC Invited Speaker Honoraria Policy

IASLC Commercial Relationships Agreement


Participants who complete a pre-and post-test along with an evaluation will receive 1 AMA PRA Category 1 CreditTM for each completed webinar.   
 
If you are interested in obtaining the CME Credits for these sessions you must indicate this when you register for the program. CME credit is only available to attendees of the live webinar.

Financial/Commercial Relationships DISCLOSURES 

A Conflict of Interest (COI) is created and exists when individuals in a position to control the content of CME, or their spouses/partners, that have a relevant personal financial relationship within the past 12 months with a commercial interest that produces, markets, re-sells, or distributes health care goods or services consumed by, or used, on patients that benefits the individual in any financial amount and therefore, may bias their opinions and teachings. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or any other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research and clinical trials), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities for which remuneration is received or expected. 

 This IASLC CME educational activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and, include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

IASLC CME assures that the planners/reviewers/authors/faculty/moderators/peer reviewers et. al. conflicts of interest  were identified, reviewed and resolved from all individuals involved in the development  or able to influence and control the content of this CME activity; IASLC CME assures that disclosure is given prior to an educational activity being delivered to learners.  Any individual who failed or refused to disclose relevant financial relationships was disqualified from this CME activity and removed from any of IASLC CME activity presentation.

All commercial relationships and conflicts of interest that are identified are thoroughly vetted by IASLC Ethics Committee, CME Subcommittee, and Independent reviewer. COI will be evaluated by the Board of Directors of the IASLC for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. IASLC CME is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial entity.

 

CREDIT STATEMENT

IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.               

IASLC CME designates this Internet Live Course activity for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

GOAL & PURPOSE

This webinar will discuss the known biological effects of smoking on cancer cell biology and emphasize the clinical effects of continued smoking in patients with lung cancer treated with surgery, chemotherapy and/or radiotherapy. We also address the variables to consider in the design and implementation of a sustainable tobacco cessation program for lung cancer patients.

TARGET AUDIENCE

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.

DISCLAMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Thank you for your participation.

DOWNLOAD RECORDING

Location Local time Time zone UTC offset
Los Angeles (U.S.A. - California) Wednesday, January 21, 2015 at 5:00:00 PM PST UTC-8 hours
Denver (U.S.A. - Colorado) Wednesday, January 21, 2015 at 6:00:00 PM MST UTC-7 hours
Chicago (U.S.A. - Illinois) Wednesday, January 21, 2015 at 7:00:00 PM CST UTC-6 hours
New York (U.S.A. - New York) Wednesday, January 21, 2015 at 8:00:00 PM EST UTC-5 hours
London (United Kingdom - England) Thursday, January 22, 2015 at 1:00:00 AM GMT UTC
Paris (France) Thursday, January 22, 2015 at 2:00:00 AM CET UTC+1 hour
Hong Kong (Hong Kong) Thursday, January 22, 2015 at 9:00:00 AM HKT UTC+8 hours
Tokyo (Japan) Thursday, January 22, 2015 at 10:00:00 AM JST UTC+9 hours
Corresponding UTC (GMT) Thursday, January 22, 2015 at 01:00:00